相关实验视频
Updated: Jul 10, 2025

Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
喘发病率测量跨黑人种族小组的喘发病率
Leah Ishmael1, Andrea Apter2, Paula J Busse3
1Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Fla.
黑人成年人经历不成比例的高喘率. 这项研究发现,与非裔美国成年人相比,多民族黑人 (ME/B) 个人,特别是波多黎各黑拉丁人成年人,面临着与喘相关的急诊和系统性皮质类固醇使用的更高风险.
科学领域:
- 肺部医学 肺部医学
- 健康差距 研究 研究 研究 研究
- 流行病学 流行病学
背景情况:
- 黑人成年人面临不成比例的高喘负担.
- 现有的研究往往将黑人人口视为一个单一的群体,忽视了关键的祖先和文化差异.
- 了解这些差异对于解决喘健康差异至关重要.
研究的目的:
- 为了调查喘发病率是否在不同黑人种族小组之间有所不同.
- 为了确定黑人人口中经历较高的喘相关健康问题的特定子组.
主要方法:
- 准备试验招募了美国和波多黎各中度至重度喘的成年人.
- 根据自我认同,参与者被分为多民族黑人 (ME/B) 和非裔美国人 (AA/B) 群体.
- 喘发病率,包括需要全身皮质类固醇 (SCs) 的恶化,急诊室/急诊室 (ED/UC) 访问和住院治疗,使用多变量回归进行了比较.
主要成果:
- 与AA/B参与者相比,ME/B参与者更年轻,更有可能居住在美国东北部,说西班牙语,BMI和健康素养较低,并患上较少的并发症,但血中异氨基酸细胞数量较高.
- 与AA/B个体相比,ME/B个体的ED/UC访问 (IRR=1.34) 和SC使用 (IRR=1.27) 对喘的可能性显著更高.
- 在ME/B组中,波多黎各黑拉丁语参与者与AA/B参与者相比,ED/UC访问 (IRR=1.64) 和SC使用 (IRR=1.43) 的可能性明显更高. 没有观察到住院治疗的显著差异.
结论:
- 多民族黑人成年人,特别是波多黎各黑拉丁人,患喘相关的急诊和系统性皮质类固醇使用的风险较高.
- 这些发现凸显了黑人人口在喘发病率方面的异质性.
- 考虑到种族和文化因素的定制干预措施是必要的,以有效地管理各种黑人社区的喘.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
相关概念视频
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...